Research is exploring the possibility of semaglutide boosting ovulation in women with obesity and PCOS, but concerns exist over the safety of pregnant women using GLP-1 receptor agonists.
[
add
]
[
|
|
...
]
Research is exploring the possibility of semaglutide boosting ovulation in women with obesity and PCOS, but concerns exist over the safety of pregnant women using GLP-1 receptor agonists.